A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

Last updated: November 26, 2025
Sponsor: Memorial Sloan Kettering Cancer Center
Overall Status: Active - Not Recruiting

Phase

2

Condition

Prostate Cancer, Early, Recurrent

Adenocarcinoma

Prostate Cancer

Treatment

Exercise Therapy

Clinical Study ID

NCT05751434
22-419
  • Ages > 18
  • Male

Study Summary

The purpose of this study is to find out the effects of exercise therapy on indicators of prostate cancer in people with low-risk prostate cancer who are on active surveillance. The exercise therapy in this study will be regular home-based walking sessions on a treadmill, and that therapy will be assigned by an exercise physiologist (a medical professional who studies how exercise affects the human body). Some participants in this study will have the assigned exercise therapy, and some participants will participate in their usual exercise routines. Researchers will compare how the assigned exercise therapy and the usual exercise routines affect indicators of prostate cancer in participants. This study will not provide treatment for prostate cancer.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age ≥ 18

  • Men with histologically confirmed localized prostate cancer undergoing activesurveillance.

  • Inactive, defined as not meeting the national exercise guidelines for cancerpatients (<150 minutes/week of moderate or vigorous exercise)43 as assessed byremote activity and heart rate tracking for a 7-day period prior to study entry (general physical activity screening assessment via smart watch).

  • Screening clearance by an MSK Exercise Physiologist (i.e., review of ECG)

  • BMI <40 kg/m^2

  • Cleared for exercise participation as per pre-screening clearance via the PhysicalActivity Readiness Questionnaire (PAR-Q+) (Appendix B)

Exclusion

Exclusion Criteria:

  • Enrollment in any other program that may alter the impact of exercise on tumoroutcomes (e.g., weight loss program)

  • Any neoadjuvant anticancer treatment of any kind for prostate cancer in the last 5years

  • Any history of systemic anticancer therapy in the last 15 years

  • Distant metastatic malignancy of any kind

  • Any other condition or intercurrent illness that, in the opinion of theinvestigator, makes the subject a poor candidate for study participation

Study Design

Total Participants: 36
Treatment Group(s): 1
Primary Treatment: Exercise Therapy
Phase: 2
Study Start date:
February 10, 2023
Estimated Completion Date:
February 10, 2027

Connect with a study center

  • University of California, Los Angeles (Data and Specimen Analysis Only)

    Los Angeles, California 90095-1781
    United States

    Site Not Available

  • University of California, Los Angeles (Data and Specimen Analysis Only)

    Los Angeles 5368361, California 5332921 90095-1781
    United States

    Site Not Available

  • Hartford Healthcare Alliance (Data collection only)

    Hartford, Connecticut 06102
    United States

    Site Not Available

  • Hartford Healthcare Alliance (Data collection only)

    Hartford 4835797, Connecticut 4831725 06102
    United States

    Site Not Available

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

    Basking Ridge, New Jersey 07920
    United States

    Site Not Available

  • Memorial Sloan Kettering Monmouth (Limited protocol activities)

    Middletown, New Jersey 07748
    United States

    Site Not Available

  • Memorial Sloan Kettering Bergen (Limited protocol activities)

    Montvale, New Jersey 07645
    United States

    Site Not Available

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

    Basking Ridge 5095409, New Jersey 5101760 07920
    United States

    Site Not Available

  • Memorial Sloan Kettering Monmouth (Limited protocol activities)

    Middletown 5101170, New Jersey 5101760 07748
    United States

    Site Not Available

  • Memorial Sloan Kettering Bergen (Limited protocol activities)

    Montvale 5101361, New Jersey 5101760 07645
    United States

    Site Not Available

  • Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities)

    Commack, New York 11725
    United States

    Site Not Available

  • Memorial Sloan Kettering Westchester (Limited protocol activities)

    Harrison, New York 10604
    United States

    Site Not Available

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York 10065
    United States

    Site Not Available

  • Memorial Sloan Kettering Nassau (Limited protocol activites)

    Rockville Centre, New York 11553
    United States

    Site Not Available

  • Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities)

    Commack 5113412, New York 5128638 11725
    United States

    Site Not Available

  • Memorial Sloan Kettering Westchester (Limited protocol activities)

    Harrison 5120095, New York 5128638 10604
    United States

    Site Not Available

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York 5128581, New York 5128638 10065
    United States

    Site Not Available

  • Memorial Sloan Kettering Nassau (Limited protocol activites)

    Rockville Centre 5134203, New York 5128638 11553
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.